In-ICU-acquired infections in flare-up systemic rheumatic disease patients receiving immunosuppressant
暂无分享,去创建一个
Z. Amoura | A. Combes | Matthieu Schmidt | F. Cohen-Aubart | J. Haroche | A. Mathian | C. Luyt | N. Brechot | M. Pineton de Chambrun | Q. Moyon | G. Hékimian | F. Assan | P. Quentric | Pierre Bay | M. Schmidt | P. Bay
[1] J. Chiche,et al. Causes of acute respiratory failure in patients with small-vessel vasculitis admitted to intensive care units: a multicenter retrospective study , 2021, Annals of Intensive Care.
[2] P. Demondion,et al. Outcomes of severe systemic rheumatic disease patients requiring extracorporeal membrane oxygenation , 2021, Annals of Intensive Care.
[3] A. Demoule,et al. Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study , 2020, Critical Care.
[4] F. Garnier,et al. One-year outcome of critically ill patients with systemic rheumatic disease: a multicenter cohort study. , 2020, Chest.
[5] C. Guitton,et al. Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study , 2017, Annals of Intensive Care.
[6] E. Ben-Chetrit,et al. Prognosis of Patients with Rheumatic Diseases Admitted to Intensive Care , 2017, Anaesthesia and intensive care.
[7] Peggy Cruse,et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] A. Wilmer,et al. Outcome of patients with systemic diseases admitted to the medical intensive care unit of a tertiary referral hospital: a single-centre retrospective study , 2016, Scandinavian journal of rheumatology.
[9] P. Asfar,et al. Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study , 2015, Critical Care.
[10] J. Chiche,et al. Outcomes in Critically Ill Patients With Systemic Rheumatic Disease: A Multicenter Study , 2015 .
[11] E. P. Dellinger,et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] M. Rybojad,et al. Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases. , 2013, European journal of internal medicine.
[13] E. P. Dellinger,et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[14] Richard Colgan,et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Sanjay Saint,et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] E. P. Dellinger,et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] D. Warren,et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] T. Welte,et al. Predicting outcome and survival in patients with Wegener's granulomatosis treated on the intensive care unit , 2007, Scandinavian journal of rheumatology.
[19] A. Wernerson,et al. Pharmacodynamics of Rituximab in Kidney Allotransplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] C. Mélot,et al. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit , 2005, Intensive Care Medicine.
[21] D. Karnad,et al. Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. , 2002, Critical care clinics.
[22] U. Hofmann,et al. Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency. , 2002, Kidney international.
[23] S. Chevret,et al. Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. , 1997, The Journal of rheumatology.
[24] C. Chastang,et al. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. , 1992, Annals of the rheumatic diseases.
[25] W. Mccune,et al. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. , 1988, The New England journal of medicine.
[26] K. Carroll,et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] M. Fleck,et al. Outcomes and Prognostic Factors in Patients with Rheumatologic Diseases Admitted to the ICU. , 2015, Internal medicine.
[28] F. Juma. Effect of liver failure on the pharmacokinetics of cyclophosphamide , 2004, European Journal of Clinical Pharmacology.